XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common stock
Capital in excess of par value
Retained earnings
Accumulated  other comprehensive (loss) income
Treasury stock
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 128,526,137            
Treasury Stock, Shares (21,738,838)            
Beginning Balance at Dec. 31, 2019 $ 6,229 $ 16 $ 3,823 $ 4,118 $ (717) $ (1,023) $ 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 125     124     1
Cumulative translation adjustment (452)       (452)    
Gains (losses) on derivatives qualifying as hedges; net of tax 1       1    
Pension liability and postretirement adjustment; net of tax 4       4    
Cash dividends declared (80)     (80)      
Stock options/SSARs 0   (1)     $ 1  
Stock options/SSARs, shares           13,763  
Vested restricted stock units and awards (1)   (2)     $ 1  
Vested restricted stock units and awards, shares           11,195  
Stock-based compensation 9   9        
Redeemable NCI 6   6        
Ending Balance at Mar. 31, 2020 $ 5,841 16 3,835 4,162 (1,164) $ (1,021) 13
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 128,526,137            
Treasury Stock, Shares (21,713,880)            
Common stock, shares issued 128,526,137            
Treasury Stock, Shares (21,588,147)            
Beginning Balance at Dec. 31, 2020 $ 6,322 16 3,853 4,156 (698) (1,017) 12
Beginning Balance, shares at Dec. 31, 2020 (21,588,147)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ (41)     (42)     1
Cumulative translation adjustment (417)       (417)    
Gains (losses) on derivatives qualifying as hedges; net of tax 4       4    
Pension liability and postretirement adjustment; net of tax 9       9    
Cash dividends declared (192)     (192)      
Stock options/SSARs 6   1     $ 5  
Stock options/SSARs, shares           98,729  
Vested restricted stock units and awards 0   (4)     $ 4  
Vested restricted stock units and awards, shares           82,461  
Stock-based compensation 11   11        
Impact of N&B Merger $ 15,980 18 15,936       26
Impact of N&B Merger (in shares) 141,740,461            
Redeemable NCI $ (1)   (1)        
Ending Balance at Mar. 31, 2021 $ 21,681 $ 34 $ 19,796 $ 3,922 $ (1,102) $ (1,008) $ 39
Ending Balance, shares at Mar. 31, 2021 (21,406,957)            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common stock, shares issued 270,266,598            
Treasury Stock, Shares (21,406,957)